The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -50,182 |
| Depreciation | 1,425 |
| Loss on disposal of property and equipment | -1,915 |
| Stock-based compensation | 8,135 |
| Non-cash lease (gain) expense | 489 |
| Change in fair value of warrant liabilities | -787 |
| Change in accrued interest and net accretion of discounts on short-term investments | 188 |
| Prepaid expenses and other current assets | -809 |
| Accounts payable | -272 |
| Accrued expenses | -4,227 |
| Right-of-use assets | 5,285 |
| Lease liabilities | -6,520 |
| Other noncurrent assets | -20 |
| Net cash used in operating activities | -45,076 |
| Purchases of property and equipment | 132 |
| Purchases of available-for-sale investments | 21,340 |
| Proceeds from sales and maturities of available-for-sale investments | 53,619 |
| Net cash provided by investing activities | 32,147 |
| Proceeds from issuance of class a common stock and pre-funded warrants in connection with registered direct offering | 5,865 |
| Issuance costs related to issuance of class a common stock and pre-funded warrants in connection with registered direct offering | 696 |
| Proceeds from note payable | 576 |
| Payments on note payable | 51 |
| Proceeds from exercise of stock options | 67 |
| Net cash provided by financing activities | 5,761 |
| Change in cash, cash equivalents and restricted cash | -7,168 |
| Cash, cash equivalents and restricted cash, beginning of year | 10,673 |
| Cash, cash equivalents and restricted cash, end of year | 3,505 |
Vicarious Surgical Inc. (RBOTW)
Vicarious Surgical Inc. (RBOTW)